A severe exhibitionist has been treated with the combination of an LHRH agonist and the antiandrogen flutamide in order to maximize androgen blocking and to control his severe deviant behaviour. The results obtained show that the androgen blockade ended his exhibitionistic behaviour and markedly decreased his sexual fantasies and activities, especially masturbation, without significant side effects.
References
1.
BerlinF.S.Sex offenders: a biomedical perspective and a status report on biomedical treatment. In: GreereJ.R., StuartI.R., eds. Sexual aggressor.New York: Van Nostrand Reinhold,1983: 83–123.
2.
BradfordJ.M.Organic treatment for the male sexual offender.Behavioral Sciences and the Law1985: 3(4): 355–375.
3.
BrecherE.M.Treatment programs for sex offenders. National Institute of Law Enforcement and Criminal Justice, Law Enforcement Assistance Administration, United States Department of Justice, 1978.
4.
CooperA.J.Progestagens in the treatment of male sex offenders: a review.Can J Psychiatry1986; 31(1): 73–79
5.
WinczeJ.P., BassalS., MalamudM.Effects of medroxy-progesterone acetate on subjective arousal, arousal of erotic stimulation and nocturnal penile tumescence in male sex offenders.Arch Sex Behav1896; 15(4): 293–305.
6.
BancroftJ., TennentG., LoucasK.The control of deviant sexual behavior by drugs.Br J Psychiatry1974; 125: 310–315.
7.
LabrieF., DupontA., BelangerA.Complete androgen blockade for the treatment of prostate cancer. In: De VitaV.T.Jr, HellmanS., RosenbergS.A., eds. Important advances in oncology.Philadelphia, PA: J.B. Lippincott Co,1985: 193–217.
8.
EgleN., AltweinJ.Post puberal castration and prostatic carcinoma.Urology1975; 6: 471–473.
9.
LabrieF., DupontA., BelangerA.New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.J Clin Invest Med1982; 5: 267–275.
10.
RousseauL., DupontA., LabrieF.Sexuality and anti-hormonal therapy in prostate cancer. In: EicherW., KockottG., eds. Sexology.Berlin Heidelberg: Springer-Verlag,1988a: 290–303.
11.
RousseauL., LabrieF., DupontA.Changes in sexuality in prostate cancer patients receiving the anti-hormonal therapy combining an anti-androgen with medical (LHRH agonist) or surgical castration.Arch Sex Behav1988b; 17(1): 87–98.
12.
HathawayS., MeehlP.An atlas for the clinical use of the MMPI.Minneapolis, MN: Minnesota Press,1951.
13.
BeckA.T., WardC.H., MendelsonM.An inventory for measuring depression.Arch Gen Psychiatry1961; 4 (June): 53–63.
14.
SpielbergerC.D., GorsuchR.L., LuscheneR.E.Manual for the State-Trait Anxiety Inventory.Palo Alto, CA: Consulting Psychologists,1970.
15.
LindeR., DoelleG.C., AlexanderN.Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonodotropin-releasing hormone agonist in normal men.N Engl J Med1981; 305(12): 663–667.
16.
BhasinS., HeberD., SteinerB.S.Hormonal effects of GnRH agonist in the human male. III. Effects of long-term combined treatment with GnRH agonist and androgen.J Clin Endocrinol Metab1985; 60: 998.
17.
BhasinS., YuanQ.X., SteinerB.S.Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.J Clin Endocrinol Metab1987; 65(3): 568–574.
18.
BouchardP., BlondetC., SpitzI.Sperm suppression by long acting GnRH agonist therapy in men: critical effects of testosterone substitution and duration of therapy (abstract).Endocrinology1986; 118: 155A.
19.
DoelleG.C., AlexanderA.N., EvansR.M.Combined treatment with a LHRH agonist and testosterone in man: reversible oligospermia without impotence.J Androl1983; 4: 298.
20.
PavlouS.N., InterlandiJ.W., WakefieldG.Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high dose LHRH analogue plus testosterone.J Androl1986; 7: 228.
21.
BradfordJ.M.W.The assessment and treatment of child molesters. American Psychiatric Association continuing education course. Presented at the annual meeting of the American Psychiatric Association. Montréal, PQ: May 7–12, 1988.
